Literature DB >> 22871646

Echinoclerodane A: a new bioactive clerodane-type diterpenoid from a gorgonian coral Echinomuricea sp.

Ching-Hsiao Cheng1, Hsu-Ming Chung, Tsong-Long Hwang, Mei-Chin Lu, Zhi-Hong Wen, Yueh-Hsiung Kuo, Wei-Hsien Wang, Ping-Jyun Sung.   

Abstract

A new clerodane-type diterpenoid, echinoclerodane A (1), was isolated from a Formosan gorgonian coral Echinomuricea sp. The structure of 1 was elucidated by spectroscopic methods. Echinoclerodane A (1) is the first clerodane-type compound obtained from the marine organisms belonging to the phylum Cnidaria. Echinoclerodane A (1) exhibited moderate cytotoxicity toward MOLT-4, HL-60, DLD-1 and LoVo tumor cells and inhibitory effects on the generation of superoxide anion and the release of elastase by human neutrophils.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22871646      PMCID: PMC6268545          DOI: 10.3390/molecules17089443

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

The search for bioactive natural products from marine organisms has been remarkably successful and gorgonian corals have proven to be rich sources of interesting natural terpenoid derivatives [1,2]. In previous studies, two bisabolane-type sesquiterpenoids, (7S,10R)-(+)-10,11-epoxycurcuphenol and (+)-curcuphenol; a labdane-type diterpenoid, echinolabdane A; and a steroid analogue, 6-epi-yonarasterol B, had been isolated from a Formosan gorgonian coral identified as Echinomuricea sp. (Plexauridae) [3,4]. In continuation of our search for new natural products from the marine invertebrates collected off the waters of Taiwan at the intersection of the Kuroshio current and the South China Sea surface current, we have further isolated a new clerodane-type diterpenoid, echinoclerodane A (1), from Echinomuricea sp. (Figure 1). In this paper, we describe the isolation, structure determination and biological activities of diterpenoid 1.
Figure 1

Structures of echinoclerodane A (1) and dytesinin A (2).

Structures of echinoclerodane A (1) and dytesinin A (2).

2. Results and Discussion

Echinoclerodane A (1) was isolated as an oil and its molecular formula was determined to be C20H30O3 (m/z 341.2095 [M+Na]+) using HRESIMS. The IR spectrum of 1 showed bands at 3,318 and 1,741 cm–1, consistent with the presence of hydroxy and ester carbonyl groups. The 13C-NMR for 1 confirmed the presence of 20 carbon signals (Table 1), which were characterized by the DEPT spectrum as three methyls, eight sp3 methylenes, three sp3 methines, three sp3 quaternary carbons, one sp2 methine and two sp2 quaternary carbons. A suite of resonances at δC 171.8 (s, C-15), 171.2 (s, C-13), 116.9 (d, C-14) and 99.2 (s, C-16), could be assigned to an α,β-unsaturated-γ-hydroxy-γ-lactone moiety. Thus, from the reported data, the proposed skeleton of 1 was suggested to be a diterpenoid with four rings.
Table 1

1H- (400 MHz, CDCl3) and 13C- (100 MHz, CDCl3) NMR data, 1H–1H COSY and HMBC correlations for diterpenoid 1.

PositionδH (J in Hz)δC, Mult.1H–1H COSYHMBC (H→C)
1a/b0.75 dd (8.4, 2.8); 1.42 m19.9, CH2H2-2, H-10C-9, -10
2a/b1.19 m; 1.49 m23.2, CH2H2-1, H2-3 C-1, -3, -4
31.58 m32.1, CH2H2-2C-4, -18
4 17.4, C
5 26.3, C
6a/b1.02 m; 1.80 td (14.0, 2.8)27.6, CH2H2-7 C-5, -7, -8, -10, -18
7a/b1.35 m; 1.92 tt (14.0, 4.0)27.9, CH2H2-6, H-8C-6, -8, -19
81.68 m35.6, CHH2-7, H3-19C-6, -7, -9, -19
9 39.1, C
101.64 dd (12.4, 4.0)40.9, CHH2-1C-8, -9, -10, -20
111.39 m; 1.59 m35.5, CH2H2-12 C-8, -9, -12
122.35 dd (8.8, 7.2)21.5, CH2H2-11, H-14 C-11, -13, -14, -16
13 171.2, C
145.84 br s116.9, CHH2-12C-12, -13,-15
15 171.8, C
166.01 s99.2, CH C-13, -15
171.04 s22.4, CH3 C-3, -4, -5
18a/b0.13 d (4.4); 0.52 d (4.4)24.5, CH2 C-3, -4, -5, -6, -10, -17
190.97 d (7.2)14.2, CH3H-8C-7, -8, -9
201.00 s19.8, CH3 C-8, -9
1H- (400 MHz, CDCl3) and 13C- (100 MHz, CDCl3) NMR data, 1H1H COSY and HMBC correlations for diterpenoid 1. From a 1H1H COSY experiment (Table 1 and Figure 2), it was possible to establish the spin systems that map out the proton sequences from H-10/H2-1/H2-2/H2-3, H2-6/H2-7/H-8/H3-19, H2-11/H2-12 and H2-12/H-14 (by allylic coupling), which was accomplished with the assistance of an HMBC experiment (Table 1 and Figure 2).
Figure 2

The 1H–1H COSY and selective key HMBC (protons→quaternary carbons) correlations for 1.

The 1H1H COSY and selective key HMBC (protons→quaternary carbons) correlations for 1. The key HMBC correlations between the protons and quaternary carbons of 1, including H2-2, H2-3, H3-17, H2-18/C-4; H2-6, H3-17, H2-18/C-5; H2-1, H-8, H-10, H2-11, H3-19, H3-20/C-9; H2-12, H-14, H-16/C-13; and H-14, H-16/C-15, permitted elucidation of the carbon skeleton. The tertiary methyls at C-4 and C-9 were confirmed by the HMBC correlations between H3-17/C-3, -4, -5 and H3-20/C-8, -9. The methine unit at δC 99.2 (d, C-16) was more shielded than expected for an oxygenated C-atom and correlated with a methine proton at δH 6.01 (H-16) in the HMQC spectrum, and this proton showed a 2J-correlation and a 3J-correlation with C-13 and C-15, respectively, in the HMBC spectrum and concluded to be a part of a hemiketal constellation. The relative configuration of 1 was elucidated mainly from a NOESY spectrum as being compatible with that of 1 offered by computer modeling [5], in which the close contacts of atoms in space calculated were consistent with the NOESY correlations (Figure 3). In the NOESY spectrum of 1, the correlations of H-10 with H2-11 and H3-19, indicated that these protons (H-10, H2-11 and H3-19) were situated on the same face and these were assigned as β protons, since the C-20 methyl is an α-substituent at C-9. An endo H-C18 proton exhibited a correlation with Me-20, suggesting that the cyclopropane moiety between C-4/5 was α-oriented. Based on the above findings, the main structure of 1 was elucidated unambiguously, and the chiral carbons for 1 were assigned as 4S*, 5S*, 8S*, 9S*, 10R* although the relative configuration for 16-hydroxy group could not be determined at this stage by this method. By comparison of the spectral data, echinoclerodane A (1) was found to be the 8-epimer of a known marine-derived clerodane-type diterpenoid, dytesinin A (2) (Figure 1), isolated from an Okinawa tunicate Cystodytes sp. [6].
Figure 3

The computer-generated model of 1 using MM2 force field calculations and the calculated distances (Å) between selected protons with key NOESY correlations.

The computer-generated model of 1 using MM2 force field calculations and the calculated distances (Å) between selected protons with key NOESY correlations. The cytotoxicity of diterpenoid 1 against the K562 (human erythromyeloblastoid leukemia), MOLT-4 (human acute lymphoblastic leukemia), HL-60 (human acute promyelocytic leukemia), DLD-1 (human colorectal adenocarcinoma), LoVo (human colorectal adenocarcinoma) and DU-145 (human prostate carcinoma) cells was studied, and the results were shown in Table 2. These data showed that echinoclerodane A exhibited moderate cytotoxicity against MOLT-4, HL-60, DLD-1 and LoVo cells. The in vitro anti-inflammatory effects of diterpenoid 1 were also tested. Echinoclerodane A (1) displayed a significant inhibition effect on the generation of superoxide anion (inhibition rate 68.6%) and this compound showed a moderately inhibition effect (inhibition rate 35.4%) on the release of elastase by human neutrophils at a concentration of 10 μg/mL, respectively [7].
Table 2

Cytotoxic activity of diterpenoid 1.

CompoundsCell lines IC50 (μM)
K562MOLT-4HL-60DLD-1LoVoDU-145
137.0513.1814.8923.4421.6953.93
Doxorubicin a0.290.0010.084.001.650.01

Doxorubicin was used as positive control.

Cytotoxic activity of diterpenoid 1. Doxorubicin was used as positive control.

3. Experimental

3.1. General Experimental Procedures

Optical rotation values were measured with a Jasco-P1010 digital polarimeter. Infrared spectra were obtained on a Varian Diglab FTS 1000 FT-IR spectrophotometer. NMR spectra were recorded on a Varian Mercury Plus 400 FT-NMR at 400 MHz for 1H and 100 MHz for 13C in CDCl3 at 25 °C. Proton chemical shifts were referenced to the residual CHCl3 signal (δH 7.26 ppm). 13C-NMR spectra were referenced to the center peak of CDCl3 at δC 77.1 ppm. ESIMS and HRESIMS data were recorded on Bruker APEX II mass spectrometer. Column chromatography was performed on silica gel (230–400 mesh, Merck, Darmstadt, Germany). TLC was carried out on precoated Kieselgel 60 F254 (0.25 mm, Merck) and spots were visualized by spraying with 10% H2SO4 solution followed by heating. HPLC was performed using a system comprised of a Hitachi L-7100 pump, a Hitachi L-7455 photodiode array detector and a Rheodyne 7725 injection port. A normal phase column (Hibar 250 × 10 mm, Merck, silica gel 60, 5 μm) was used for HPLC.

3.2. Animal Material

Specimens of the gorgonian coral Echinomuricea sp. were collected by hand using scuba equipment off the coast of the southern Taiwan and stored in a freezer until extraction. This organism was identified by comparison with previous descriptions [8,9]. A voucher specimen (NMMBA-TW-GC-127) was deposited in the National Museum of Marine Biology and Aquarium, Taiwan.

3.3. Extraction and Isolation

The freeze-dried and minced material of Echinomuricea sp. (wet weight 1.68 kg, dry weight 428 g) was extracted with a 1:1 mixture of methanol (MeOH) and dichloromethane (CH2Cl2). The residue was partitioned with ethyl acetate (EtOAc) and H2O. The EtOAc phase was further partitioned between MeOH and n-hexane. The n-hexane phase was separated by silica gel and eluted using n-hexane/EtOAc/MeOH to yield 21 fractions A–U. Fraction N was separated on Sephadex LH-20 and eluted using a 1:1 mixture of MeOH/CH2Cl2 to yield 13 fractions. Fraction N3 was purified by NP-HPLC using a mixture of n-hexane and EtOAc (8:1, flow rate 5 mL/min) as the mobile phase to afford compound echinoclerodane A (1) (8.3 mg); oil; −43 (c 0.07, CHCl3); IR (neat) νmax 3,318, 1,741 cm–1; 1H- (CDCl3, 400 MHz) and 13C- (CDCl3, 100 MHz) NMR data, see Table 1; ESIMS m/z 341 [M+Na]+; HRESIMS: m/z 341.2095 (calcd. for C20H30O3Na, 341.2093).

3.4. Molecular Mechanics Calculations

The implementation of the MM2 force field [5] in the CHEM3D PRO software from CambridgeSoft Corporation (Cambridge, MA, USA; ver. 9.0, 2005) was used to calculate the molecular models.

3.5. Cytotoxicity Testing

The cytotoxicity of diterpenoid 1 was assayed with a modification of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric method according to previously described procedures [10,11].

3.6. Superoxide Anion Generation and Elastase Release by Human Neutrophils

Human neutrophils were obtained by means of dextran sedimentation and Ficoll centrifugation. Superoxide generation and elastase release were carried out according to the procedures described previously [12,13]. Briefly, superoxide anion production was assayed by monitoring the superoxide dismutase-inhibitable reduction of ferricytochrome c. Elastase release experiments were performed using MeO-Suc-Ala-Ala-Pro-Valp-nitroanilide as the elastase substrate.

4. Conclusions

Clerodane-type diterpenoids are extensively present in terrestrial plants [14], and compounds of this type were also obtained from tunicates [6]. Octocorals have been proven to be rich sources of natural terpenoid derivatives and terpenoid analogues are often found in large amounts in marine invertebrates [15]. It is worth noting that the new clerodane metabolite 1 (echinoclerodane A) is the first clerodane-type derivative isolated from the marine organisms belonging to the phylum Cnidaria and this compound exhibited cytotoxicity and anti-inflammatory activity. The study material Echinomuricea sp. has begun to be transplanted to culturing tanks with a flow-through sea water system located in the National Museum of Marine Biology and Aquarium, Taiwan for the extraction of additional natural products in order to establish a stable supply of bioactive material. Sample Availability: Not Available.
  8 in total

Review 1.  Marine natural products.

Authors:  John W Blunt; Brent R Copp; Robert A Keyzers; Murray H G Munro; Michèle R Prinsep
Journal:  Nat Prod Rep       Date:  2011-12-22       Impact factor: 13.423

Review 2.  Diterpenoids of terrestrial origin.

Authors:  James R Hanson
Journal:  Nat Prod Rep       Date:  2011-06-28       Impact factor: 13.423

3.  The hederagenin saponin SMG-1 is a natural FMLP receptor inhibitor that suppresses human neutrophil activation.

Authors:  Tsong-Long Hwang; Chien-Chiao Wang; Yao-Haur Kuo; Hui-Chi Huang; Yang-Chang Wu; Liang-Mou Kuo; Yi-Hsiu Wu
Journal:  Biochem Pharmacol       Date:  2010-06-25       Impact factor: 5.858

4.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

Authors:  M C Alley; D A Scudiero; A Monks; M L Hursey; M J Czerwinski; D L Fine; B J Abbott; J G Mayo; R H Shoemaker; M R Boyd
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

5.  2-(2-Fluorobenzamido)benzoate ethyl ester (EFB-1) inhibits superoxide production by human neutrophils and attenuates hemorrhagic shock-induced organ dysfunction in rats.

Authors:  Huang-Ping Yu; Pei-Wen Hsieh; Yi-Ju Chang; Pei-Jen Chung; Liang-Mou Kuo; Tsong-Long Hwang
Journal:  Free Radic Biol Med       Date:  2011-03-30       Impact factor: 7.376

Review 6.  Diterpenes from gorgonian corals.

Authors:  Fabrice Berrue; Russell G Kerr
Journal:  Nat Prod Rep       Date:  2009-03-25       Impact factor: 13.423

7.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

Authors:  D A Scudiero; R H Shoemaker; K D Paull; A Monks; S Tierney; T H Nofziger; M J Currens; D Seniff; M R Boyd
Journal:  Cancer Res       Date:  1988-09-01       Impact factor: 12.701

8.  Bioactive compounds from a gorgonian coral Echinomuricea sp. (Plexauridae).

Authors:  Hsu-Ming Chung; Pei-Han Hong; Jui-Hsin Su; Tsong-Long Hwang; Mei-Chin Lu; Lee-Shing Fang; Yang-Chang Wu; Jan-Jung Li; Jih-Jung Chen; Wei-Hsien Wang; Ping-Jyun Sung
Journal:  Mar Drugs       Date:  2012-05-23       Impact factor: 6.085

  8 in total
  8 in total

Review 1.  Clerodane diterpenes: sources, structures, and biological activities.

Authors:  Rongtao Li; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Nat Prod Rep       Date:  2016-07-18       Impact factor: 13.423

2.  Corals and their potential applications to integrative medicine.

Authors:  Edwin L Cooper; Kyle Hirabayashi; Kevin B Strychar; Paul W Sammarco
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-13       Impact factor: 2.629

Review 3.  Anti-inflammatory activities of natural products isolated from soft corals of Taiwan between 2008 and 2012.

Authors:  Wen-Chi Wei; Ping-Jyun Sung; Chang-Yih Duh; Bo-Wei Chen; Jyh-Horng Sheu; Ning-Sun Yang
Journal:  Mar Drugs       Date:  2013-10-23       Impact factor: 5.118

Review 4.  Marine Natural Product Inhibitors of Neutrophil-Associated Inflammation.

Authors:  Chun-Yu Chen; Yung-Fong Tsai; Wen-Yi Chang; Shun-Chin Yang; Tsong-Long Hwang
Journal:  Mar Drugs       Date:  2016-07-26       Impact factor: 5.118

5.  Lactones with methylcyclohexane systems obtained by chemical and microbiological methods and their antimicrobial activity.

Authors:  Małgorzata Grabarczyk; Katarzyna Wińska; Wanda Mączka; Anna K Żołnierczyk; Barbara Żarowska; Mirosław Anioł
Journal:  Molecules       Date:  2015-02-16       Impact factor: 4.411

Review 6.  Natural product chemistry of gorgonian corals of the family Plexauridae distributed in the Indo-Pacific Ocean.

Authors:  Li-Hsueh Wang; Jyh-Horng Sheu; Shih-Yao Kao; Jui-Hsin Su; Yung-Husan Chen; Yu-Hsin Chen; Yin-Di Su; Yu-Chia Chang; Lee-Shing Fang; Wei-Hsien Wang; Yang-Chang Wu; Ping-Jyun Sung
Journal:  Mar Drugs       Date:  2012-11-01       Impact factor: 5.118

7.  Echinohalimane A, a bioactive halimane-type diterpenoid from a Formosan gorgonian Echinomuricea sp. (Plexauridae).

Authors:  Hsu-Ming Chung; Li-Chung Hu; Wei-Hsuan Yen; Jui-Hsin Su; Mei-Chin Lu; Tsong-Long Hwang; Wei-Hsien Wang; Ping-Jyun Sung
Journal:  Mar Drugs       Date:  2012-10-17       Impact factor: 6.085

Review 8.  Cytotoxic and cytolytic cnidarian venoms. A review on health implications and possible therapeutic applications.

Authors:  Gian Luigi Mariottini; Luigi Pane
Journal:  Toxins (Basel)       Date:  2013-12-27       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.